{"prompt": "['FLUAD vs Fluzone-HD', 'Version 5.0', 'September 25, 2018', 'Subjects NOT participating in long-term immunogenicity subset: duration of study', 'participation is 42-days post vaccination', 'Subjects participating in long-term immunogenicity subset: duration of study participation is', '181 days post-vaccination', \"The study will report only SAEs occurring during each subject's participation in the study.\", 'More information on potential risks and benefits is located under Human Subjects, section 8.3.', '5.4.3 Safety Monitoring Plan', 'Although', 'FLUAD\u00ae and FluzoneR High-Dose are licensed vaccines, there is less US safety', 'experience with these vaccines than with standard influenza vaccines, particularly for FLUAD\u00ae,', 'which was recently licensed in the United States (November 24, 2015). FluzoneR High Dose', 'was licensed on December 23, 2009 in the United States. Also, less data are available in', 'persons >80 years or for those with mild cognitive impairment than in younger, healthier adults.', 'This is the first study conducted in the CISA Project where at least one death is somewhat likely', 'to occur during the study period in a study participant (due to the older age-group of the', 'participants). Therefore, the goal of the safety monitoring plan is to protect the health of the', 'study population and ensure adequate communication of potential risks, and to provide', 'situational awareness of potential safety signals from this study to CDC Immunization Safety', 'Office (ISO) leadership. This plan is designed to monitor safety while minimizing introduction of', 'bias into the study and minimizing burden to study investigators. The safety monitoring plan is', 'described in Appendix H.', '5.5 Health-Related Quality of Life (HRQOL)', '5.5.1 Generic Measures of HRQOL', 'Late-Life Function & Disability Instrument (LLFDI) and Late-Life Function & Disability', 'Instrument - Computer Adaptive Test (LLFDI-CAT) (Year 1 Only)', 'The Late-Life FDI is an HRQOL instrument for assessing function (ability to perform discrete', 'actions or activities as part of daily routines) and disability (socially-defined tasks) in community-', 'dwelling older adults25-27 The function component is a 32-item questionnaire that assesses how', 'much difficulty a person has doing a range of upper extremity, basic lower extremity, and', 'advanced lower extremity functions. The response categories for the function instrument are', \"none, a little, some, quite a lot, cannot do in relation to the question, 'How much difficulty do you\", \"have?'. The disability component is a 16-item questionnaire that assesses how frequently a\", 'community dwelling older adult performs a particular task and the extent to which they feel', 'limited in doing the task. The response categories for the disability instrument are very often,', 'often, once in a while, almost never, never in response to \"how often do you ?\\' and not at all,', \"a little, somewhat, a lot, completely in response to 'to what extent do you feel limited in ?'\", 'Each instrument generates a raw score, scaled score, and standard error for each dimension.', 'The function component displays a total function score as well as separate scores for upper', 'extremity, basic lower extremity, and advanced lower extremity subscales. The disability', 'component displays a frequency total score, with social role and personal role subscale scores,', 'and a limitation total score, with instrumental role and management role subscale scores. The', 'scores range from 0-100 with high scores indicating higher levels of functioning and ability.', '28']['FLUAD vs Fluzone-HD', 'Version 5.0', 'September 25, 2018', 'For the function section, the minimum clinically important difference ranges from 2.7-4.3. - The', 'disability section is split into two dimensions: limitations and frequency in doing a task. For', 'limitations, the minimum clinically important difference is 16.7. For frequency, the minimum', 'clinically important difference is 7.8.', 'The Late-Life Function & Disability Instrument - Computer Adaptive Test (LLFDI-CAT) is a', 'modification of the LLFDI that expands the number of items and incorporates the World Health', \"Organization's International Classification of Functioning, Disability Health domains of activity\", 'limitations (function) and participation restriction (disability)28 (Appendix I). The Computer', 'Adaptive Test method significantly reduces administration time and respondent burden. The', 'LLFDI-CAT uses the same response categories as the LLFDI and generates similar summary', 'and subscale scores', 'These instruments have several advantages for use in this study. They provide measures', 'of', 'extremity function and multiple activities for community dwelling older adults. They are', 'validated, reliable, and responsive in older populations and various diseases. They are', 'designed for self-completion. They employ a standardized scoring system, and are free of', 'charge.', 'EQ-5D', 'The EQ-5D is a standardized, generic measure of health status that provides information on', 'health-related quality of life and activities of daily living relevant to older adults: mobility, self-', 'care, usual activities, pain/discomfort and anxiety/depression (http://www.eurogol.org/)29 In', 'addition, the instrument contains the EQ Visual Analogue Scale (EQ-VAS) which measures the', \"respondent's self-rated health.\", 'The EQ-5D-5L is the new version of the EQ-5D that increases the levels of severity from three', 'to five to significantly increase reliability and sensitivity while maintaining feasibility and reducing', 'ceiling effects (Appendix . J) 30,31 The descriptive system comprises 5 dimensions of mobility,', 'self-care, usual activities, pain/discomfort, anxiety/depression. For each of these dimensions,', 'there are 5 response levels: no problems, slight problems, moderate problems, severe', 'problems, and extreme problems. The respondent is asked to indicate his/her health state by', 'ticking in the box against the most appropriate statement in each of the 5 dimensions. This', 'decision results in a 1-digit number expressing the level selected for that dimension. The digits', \"for 5 dimensions can be combined in a 5-digit number describing the respondent's health state\", 'from 11111 as best health and 55555 as worst health These numbers are converted to a Utility', 'Index that ranges from -0.109 (worst health) to 1.000 (best health) for US specific values. The', 'minimum clinically important difference ranges from 0.05 to 0.1 depending on health conditions', \"being studied. The EQ VAS records the respondent's self-rated health on a 20 cm vertical,\", 'visual analogue scale with endpoints labelled \"the best health you can imagine\\' (100) and \"the', 'worst health you can imagine\\' (0). The respondent marks an \"X\\' on the scale number to indicate', 'how their health is \"today.\\' The minimum clinically important difference on the VAS is 8.', 'The EQ-5D-5L, EQ-VAS have several advantages for use in this study. The measure is', 'applicable to a wide range of health conditions and treatments and provide a simple descriptive', 'profile and a single index value for health status. It has been validated in US and international', 'populations and in older adults29,32,33 The measure is useful for monitoring the health status of', 'patient groups at different moments in time and assessing the seriousness of conditions at', '29']\n\n###\n\n", "completion": "END"}